SWK Holdings Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 23

Employees

  • Stock Symbol
  • SWKH

Stock Symbol

  • Investments
  • 13

  • Share Price
  • $16.49
  • (As of Tuesday Closing)

SWK Holdings General Information

Description

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Contact Information

Website
www.swkhold.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Specialized Finance
Other Industries
Private Equity
Stock Exchange
NAS
Primary Office
  • 14755 Preston Road
  • Suite 105
  • Dallas, TX 75254
  • United States
+1 (972) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SWK Holdings Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.49 $16.58 $15.26 - $19.99 $207M 12.5M 5.74K $1.25

SWK Holdings Financials Summary

In Thousands,
USD 		TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 190,708 206,252 230,051 173,591
Revenue 37,667 41,484 56,155 36,712
EBITDA 13,316 12,659 37,696 16,211
Net Income 15,875 13,491 25,929 5,202
Total Assets 315,845 299,621 282,665 273,901
Total Debt 22,000 2,445 8 11,758
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SWK Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SWK Holdings‘s full profile, request access.

Request a free trial

SWK Holdings Executive Team (20)

Name Title Board Seat Contact Info
Joe Staggs Chief Executive Officer & President
Winston Black Strategic Advisor
Yvette Heinrichson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Michael Miner Senior Analyst
You’re viewing 4 of 20 executive team members. Get the full list »

SWK Holdings Board Members (16)

Name Representing Role Since
0. 00000 00000 SWK Holdings Board Member 000 0000
000000 000000 Self Board Member 000 0000
000000 0000000000 SWK Holdings Board Member 000 0000
00000 0000000 Self Board Member 000 0000
0000000 00000 SWK Holdings Strategic Advisor 000 0000
You’re viewing 5 of 16 board members. Get the full list »

SWK Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SWK Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SWK Holdings‘s full profile, request access.

Request a free trial

SWK Holdings Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Trio Healthcare International 08-Jul-2021 00 0000000 00.00 Personal Products
Trio Healthcare International 28-Oct-2020 00 0000000 Personal Products
Enteris BioPharma 26-Aug-2019 0000000000 000.00 Drug Discovery
Cheetah Medical 14-Feb-2019 0000 00000 0000 Monitoring Equipment
Best ABT Molecular Imaging 13-Jun-2018 Bankruptcy: Admin/Reorg 000 Other Devices and Supplies
You’re viewing 5 of 13 investments. Get the full list »

Ready to get started?

Request a free trial

SWK Holdings Subsidiaries (1)

Company Name Industry Location Founded
SWK Funding Lender Dallas, TX 0000
To view SWK Holdings’s complete subsidiaries history, request access »

SWK Holdings ESG

Risk Overview

Risk Rating

Updated April, 25, 2023

26.32 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,708

Rank

00.00

Percentile

Diversified Financials

Industry

00 of 882

Rank

00.00

Percentile

Consumer Finance

Subindustry

00 of 218

Rank

00.00

Percentile

To view SWK Holdings’s complete esg history, request access »

SWK Holdings Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
Cheetah Medical 14-Feb-2019 0000 00000000000 0000 Completed
  • 000 00000000
Best ABT Molecular Imaging 13-Jun-2018 0000000000: 000000 000 Completed
  • 000 00000000
Akrimax Pharmaceuticals 01-Jan-2018 00 000000000000000 Completed
  • 000 00000000
SynCardia Systems 17-Dec-2013 00000 00000 00 0000 Completed
  • 2 buyers
Holmdel Pharmaceuticals (InnoPran XL) 20-Dec-2012 Corporate Asset Purchase 0000 Completed
  • 2 buyers
To view SWK Holdings’s complete exits history, request access »